[1]
Upadhyay, A. et al. 2022. Comparative assessment of safety and efficacy of Vortioxetine with Escitalopram in patients with MDD (Major Depressive Disorder): a randomized, comparative, parallel group, open-label study. International Journal of Pharmacological Research. 12, 3 (Mar. 2022), e5726.